Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
Over 35% of the adult US population is obese. In turn, excess adiposity increases the risk of multiple complications including type 2 diabetes (T2D), insulin resistance, and cardiovascular disease; yet, obesity also independently heightens risk of Alzheimer’s Disease (AD), even after adjusting for o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-10-01
|
| Series: | Biomarker Insights |
| Online Access: | https://doi.org/10.1177/1177271920964108 |